Summary
A wide variety of cerebrovascular disorders can complicate the clinical course of cancer patients and, in rare instances, be the presenting sign of cancer. Central nervous system (CNS) hemorrhagic or ischemic events are typically symptomatic. Hemorrhage can occur into the parenchymal, subdural, epidural, or subarachnoid compartments. Cerebral infarction may cause focal signs presenting as a transient ischemic attack or as a completed infarction, or encephalopathy secondary to multiple small infarctions. The most common mechanisms of cerebrovascular disease in the cancer patient are the presence of CNS tumor or coagulopathy. The coagulopathy is a direct effect of the neoplasm in many cases; in other cases it develops from cancer treatment, most commonly chemotherapy. Radiation therapy to extracranial or cranial sites can also result in vessel stenosis or thrombosis. It is important to identify cerebrovascular disease as the cause of neurologic symptoms in the cancer patient. Laboratory studies of coagulation function and CNS imaging techniques are useful in identifying the precise etiology of the cerebrovascular disorder. Prompt diagnosis leads to appropriate therapy, which in many patients can improve the clinical neurologic condition as well as prevent additional vascular episodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16–35.
Posner JB, Chernik NL. Intracranial metastases from systemic cancer. In BS Schoenberg (ed.): Advances in Neurology. Vol 19. New York: Raven Press, 1978: 579–592.
Kothbauer P, Jellinger K, Flament H. Primary brain tumour presenting as spontaneous intracerebral hemorrhage. Acta Neurochir 1979;49:35–45.
Little JR, Dial B, Belanger G et al. Brain hemorrhage from intracranial tumor. Stroke 1979;10:283–288.
Kondziolka D, Bernstein M, Resch L et al. Significance of hemorrhage into brain tumors: clinopathological study. J Neurosurg 1987;67:852–857.
Iwama T, Ohkuma A, Miwa Y et al. Brain tumors manifesting as intracranial hemorrhage . Neurol Med Chir 1992;32:130–135.
Nutt SH, Patchell RA. Intracranial hemorrhage associated with primary and secondary tumors. Neurosurg Clin N Am 1992;3:591–599.
Nataf F, Emery E, Kherli P, Seigneuret E. Neurosurgical multicenter study of cerebral metastases. Neurochirurgie 1999;45:369–374
Barth H, Fritsch G, Haaks T. Intracerebral hematoma as an acute manifestation of intracranial tumors. Nervenarzt 1994;65:854–858.
Otsuka S, Nakatsu S, Matsumoto S et al. Brain tumors associated with hemorrhage from tumors as their first manifestation. Nippon Geka Hokan 1989;58:147–154.
Wakai S, Yamakawa K, Manaka S et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 1982;10:437–444.
Isoda H, Takahashi M, Arai T et al. Multiple haemorrhagic brain metastases from papillary thyroid cancer. Neuroradiology 1997;39:198–202.
Mandybur TI. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977;27:650–655.
Scatliff JH, Radcliff WB, Pitman HH et al. Vascular structure of glioblastomas. Am J Radiol 1969;105:795–805.
Weller RO, Foy M, Cos S. The development and ultrastructure of the microvasculature in malignant gliomas. Neuropathol Appl Neurobiol 1977:3:307–322.
Cheng SY, Nagane M Huang HS et al. Intracerebral tumor–associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci USA 1997;94:12081–12087.
Hirano A, Matsui T. Vascular structures in brain tumors. Hum Pathol 1975;6:611–621.
Jung S, Moon KS, Jung TY et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor–associated intracerebral hemorrhage. J Neuro-oncol 2006;76:257–263.
Scott M. Spontaneous intracranial hemorrhage caused by cerebral neoplasms. J Neurosurg 1975;10:437–444.
Bosnjak R, Berham C, Popovic M et al. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J Neurosurg 2005;103:473–84.
Lazaro RP, Messer HD, Brinker RA. Intracranial hemorrhage associated with meningioma. Neurosurgery 1981;8:96–101.
Atlas SW, Grossman RI, Gomori JM et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology 1987;164:71–77.
Dylewski DA, Demchuk AM, Morgenstern LB. Utility of magnetic resonance in acute intracerebral hemorrhage. J Neuroimaging 2000;10:78–83.
Tseng SH, Liao CC, Lin SM et al. Dural metastasis in patients with malignant neoplasm and chronic subdural hematoma. Acta Neurol Scand 2003;108: 43–46.
Bromberg JE, Vandertop WP, Jansen GH. Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic leukemia. Br J Neurosurg 1998;12:373–376.
Laigle-Donadey F, Taillibert S, Mokhtari K et al. Dural metastases. J Neurooncol 2005;75:57–61.
Sunada I, Nakabayashi H, Matsusaka Y et al. Meningioma associated with acute subdural hematoma: case report. Radiat Med 1998;16: 483–486.
Minette SE, Kimmel DW. Subdural hematoma in patients with systemic cancer. Mayo Clin Proc 1989;64:637–642.
Wang AM, Chinwuba CE, O’Reilly GV et al. Subdural hematoma in patients with brain tumor: CT evaluation. J Comput Assist Tomogr 1985; 9:511–513.
Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000;54:1222–1226.
Brown MT, Friedman HS, Oakes WJ et al. Sagittal sinus thrombosis and leptomeningeal medulloblastoma. Neurology 1991;41:455–456.
Reddinghaus RE, Patte C, Couanet D et al. Dural sinus thrombosis in children with cancer. Med Pediatri Oncol 1997;29:296–302.
Kim AW, Trobe JD. Syndrome simulating pseudotumor cerebri caused by partial transverse venous sinus obstruction in metastatic prostate cancer. Am J Ophthalmol 2000;129:254–256.
Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet 2007;6:162–170.
Goldsmith P, Burn DJ, Coulthard A et al. Extrinsic cerebral venous sinus obstruction resulting in intracranial hypertension. Postgrad Med J 1999;75:550–551.
Zilkha A, Diaz AS. Computed tomography in the diagnosis of superior sagittal sinus thrombosis. J Comput Assist Tomogr 1980;4: 124–126.
Lafitte F, Boukobza M, Guichard JP et al. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis. Clin Radiol 1997;52:672–679.
Einhaupl KM, Villringer A, Meister W et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597–600.
De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;304:484–488.
Buccino G, Scoditti U, Pini M et al. Loco-regional thrombolysis in the treatment of cerebral venous and sinus thrombosis: report of two cases. Acta Neurol Scand 2001;103:59–63.
Philips MF, Bagley LJ, Sinson GP et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999;90:65–71.
Chow K, Gobin YP, Saver J et al. Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 2000;31:1420–1425.
Ho KL. Neoplastic aneurysm and intracranial hemorrhage. Cancer 1982;50:2935–2940.
Kalafut M, Vinuela F, Saver JL et al. Multiple cerebral pseudoaneurysms and hemorrhages: the expanding spectrum of metastatic cerebral choriocarcinoma. J Neuroimaging 1998;8:44–47.
Guttman DH, Cantor CR, Piacente GJ et al. Cerebral vasculopathy and infarction in a woman with carcinomatous meningitis. J Neuro-oncol 1990;9:183.
Klein P, Haley C, Wooten GF et al. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Arch Neurol 1989;46:1149–1152.
Latchaw RE, Gabrielsen TO, Seeger JF. Cerebral angiography in meningeal sarcomatosis and carcinomatosis. Neuroradiology 1974;8:131.
Rojas-Marcos I, Martin-Duverneuil N, Laigle-Donadey F et al. Ischemic stroke in patients with glioblastoma. J Neurol 2005;252:488–489.
Charache S, Adams RJ. Neurologic complications associated with disorders of red blood cells. In Handbook of Clinical Neurology Vol. 19: Systemic Diseases, Part I. Baltimore: Elsevier Science Publishers, 1993, 249–269.
Berk PD, Goldberg JD, Donovan PB et al. Therapeutic recommendations in polycythemia vera based on the Polycythemia Vera Study Group protocols. Semin Hematol 1986;23:132–143.
Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995;123:656–664.
Arboix A, Besses C, Acin P et al. Ischemic stroke as first manifestation of essential thrombocythemia: report of six cases. Stroke 1995;26:1463–1468.
Michiels JJ. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia. Clin Appli Thromb Hemost 1999;5:247–251.
Arboix A, Costa I, Besses C. Intravascular lymphomatosis: a rare etiology of recurrent cerebral ischemia. Rev Neurol 2000;30:1188–1190.
Calamia KT, Miller A, Shuster EA et al. Intravascular lymphomatosis: a report of ten patients with central nervous system involvement and a review of the literature. Adv Exp Med Biol 1999;455:249–265.
Liow K, Asmar P, Liow M et al. Intravascular lymphomatosis: contribution of cerebral MRI findings to diagnosis. J Neuroimaging 2000;10:116–118.
Roeltgen DP, Syna DR. Neurological complications of cardiac tumors. In: Goetz CG, Tanner CM, Aminoff MJ (eds.). Handbook of Clinical Neurology: Systemic Diseases, Part I. New York: Elsevier Science Publishers, 1993, 93–109.
Brebenc ML, Rosado de Christenson ML, Burke AP et al. Primary cardiac and pericardial neoplasms: radiologic–pathologic correlation. Radiographics 2000;20:1073–1103.
Liebeskind DS, Buljubasic N, Saver JL. Cardioembolic stroke due to papillary fibroelastoma. J Stroke Cerebrovasc Dis 2001;10:94–95.
Schaff HV, Mullany CJ. Surgery for cardiac myxomas. Semin Thorac Cardiovasc Surg 2000;12:77–88.
Klatt EC, Heitz DR. Cardiac metastases. Cancer 1990;65:1456–1459.
Gibbs P, Cebon JS, Calafiore P et al. Cardiac metastases from malignant melanoma. Cancer 1999;85:78–84.
Weir B, MacDonald, Mielke B. Intracranial vascular complications of choriocarcinoma. Neurosurgery 1978;2:138–142.
O’Neill BP, Dinapoli RP, Okazaki H. Cerebral infarction as a result of tumor emboli. Cancer 1987;60:90–95.
Lefkovitz NW, Roessmann UR, Kori SH. Major cerebral infarction from tumor embolus. Stroke 1986;17:555–557.
Urrutia V, Jichici D, Thomas CE et al. Embolic stroke secondary to an aortic arch tumor: a case report. Angiology 2000;51:959–962.
Alam M, Rosman HS, Grullon C. Transesophageal echocardiography in evaluation of atrial masses. Angiology 1995;46:123–128.
Araoz PA, Mulvagh SL, Tazelaar HD et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation . Radiographics 2000;20:1303–1319.
Wintersperger BJ, Becker CR, Gulbins H et al. Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol 2000;10:443–449.
Ravikumar E, Pawar N, Gnanamuthu R et al. Minimal access approach for surgical management of cardiac tumors. Ann Thorac Surg 2000;70:1077–1079.
Knepper LE, Biller J, Adams HP et al. Neurological manifestations of atrial myxoma: a 12-year experience and review. Stroke 1988;19:1435–1440.
Nielsen EH, Lindholm J, Bjerre P et al. Frequent occurrence of pituitary apoplexy in patients with nonfunctioning pituitary adenoma. Clin Endocrinol 2006;64:319–322.
Da Motta LACR, De Mello PA, De Lacerda CM et al. Pituitary apoplexy: clinical course, endocrine evaluations, and treatment analysis. J Neurosurg Sci 1999;43:25–36.
Trousseau A. Phlegmasia alba dolens. In: Clinique Medicale de L’Hotel Dieu de Paris 3, 2nd ed. Paris: Balliere, 1865.
Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Sem Thromb Hemostasis 1999;25:173–182.
Schwartz JD, Simantov R. Thrombosis and malignancy: pathogenesis and prevention. In Vivo 1998;12:619–624.
Arkel YS. Thrombosis and cancer. Semin Oncol 2000; 27:362–374.
Miljic P, Milosevic-Jovicic N, Antunovic P et al. Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency. Haematologia 2000;30:51–54.
Deitcher SR, Erban JK, Limentani SA. Acquired free protein S deficiency associate with multiple myeloma: a case report. Am J Hematol 1996;51:319–323.
Odegaard OR, Lindahl AK, Try K et al. Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiency. Thromb Res 1992;66:729–734.
Conlan MG, Mosher DF. Concomitant chronic lymphocytic leukemia, acute myeloid leukemia, and thrombosis with protein C deficiency: case report and review of the literature. Cancer 1989;63:1398–1401.
Gurgey A, Buyukpamukeu M, Baskut C et al. Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma. Med Pediatr Oncol 1997;29:224–225.
Nowak-Gottl U, Aschka I, Koch HG et al. Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia: the need for a prospective multicenter study. Blood Coagul Fibrinolysis 1995;6:761–764.
Haim N, Lanir N, Hoffman R et al. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med 2001;110:91–96.
Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombus. Am J Cancer 1938;34:566–585.
Bedikian A, Valdivieso M, Luna M et al. Nonbacterial thrombotic endocarditis in cancer patients: comparison of characteristics of patients with and without concomitant disseminated intravascular coagulation. Med Pediatri Oncol 1978;4:149–157.
Rogers LR, Cho E, Kempin S et al. Cerebral infarction from nonbacterial thrombotic endocarditis. Am J Med 1987;83:746–758.
Gonzalez Quintela A, Candela MJ, Vidal C et al. Nonbacterial thrombotic endocarditis in cancer patients. Acta Cardiol 1991;46:1–9.
Min KW, Gyorkey F, Sato C. Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenic role of tumor mucin. Cancer 1980;45:2374–2382.
MacDonald RA, Robbins SL. The significance of nonbacterial thrombotic endocarditis: an autopsy and clinical study of 78 cases. Ann Intern Med 1957;46:255–273.
Ojeda VJ, Frost F, Mastaglia FL. Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust 1985;142:629–631.
Biller J, Challa VR, Toole JF et al. Nonbacterial thrombotic endocarditis: a neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol 1982;39:95–98.
Le Ber I, Auzou P, Derumeaux G et al. Cerebrovascular complication in nonbacterial thrombotic endocarditis: value of cardiac transesophageal ultrasonography. Presse Med 1997;26:756–758.
Vassallo R, Remstein ED, Parisi JE et al. Multiple cerebral infarctions from nonbacterial thrombotic endocarditis mimicking cerebral vasculitis. Mayo Clin Proc 1999;74:798–802.
Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology 1989;39:522–526.
Towfighi J, Simmonds MA, Davidson EA. Mucin and fat emboli in mucinous adenocarcinomas. Arch Path Lab Med 1983;107:646–649.
Saver JL. Emerging risk factors for stroke: patent foramen ovale, proximal aortic atherosclerosis, antiphospholipid antibodies, and activated protein C resistance. J Stroke Cerebrovasc Dis 1997;6:167–172.
Shapiro B, Jude J, Goudemand I et al. Lupus anticoagulant: a clinical and laboratory study of 100 cases. Clin Lab Haematol 1988;10:41–51.
Schved JF, Dupuy-Fona C, Biron C et al. A prospective epidemiological study on the occurrence of antiphospholipid antibody: The Montpelier Antiphospholipid (MAP) Study. Haemostasis 1994;24:175–182.
Genvresse I, Buttgereit F, Spath-Schwalbe E et al. Arterial thrombosis associated with anticardiolipin and anti-beta 2-glycoprotein I antibodies in patients with non-Hodgkin’s lymphoma: a report of two cases. Eur J Haematol 2000;65:344–347.
Donner M, Bekassy NA, Garcwicz S et al. Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukemia. Pediatr Hematol Oncol 1992;9:377–379.
Mouas H, Lortholary O, Eclache V et al. Antiphospholipid syndrome during acute monocytic leukaemia. Eur J Haematol 1994;53:59–60.
Ruffatti A, Aversa S, Del Ross T et al. Antiphospholipid antibody syndrome associated with ovarian cancer: anew paraneoplastic syndrome? J Rheumatol 1994;21:2162–2163.
Olalla JI, Ortin M, Hermida G et al. Disappearance of lupus anticoagulant after allogenic bone marrow transplantation. Bone Marrow Transplant 1999;23:83–85.
Sun NC, McAfee WM, Hum GJ et al. Hemostatic abnormalities in malignancy: a prospective study of 108 patients. Part I. Coagulation studies. Am J Clin Pathol 1979;71:10–16.
Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586–592.
Rosen PJ. Bleeding problems in the cancer patient. Hematol Oncol Clin North Am 1992;6:1315–1328.
Re G, Lanzarini C, Visani G et al. Latent acute promyelocytic leukaemia in a case of ischaemic stroke underlines the importance of prompt diagnostic confirmation prior to acute care. Eur J Emerg Med 1995;2:102–104.
Goldberg MA, Ginsburg D, Mayer RJ et al. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 1987;69:187–191.
Wada H, Gabazza E, Nakasaki T et al. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. Semin Thromb Hemost 2000;26:17–21.
Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998;56:65–73.
Levi M, de Jonge E, van der Poll T et al. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med 2000;28(suppl):S20–S24.
Sakuragawa N, Hasegawa H, Maki M et al. Clinical evaluation of low-molecular-weight–heparin (FR-860) on disseminated intravascular coagulation (DIC): a multicenter co-operative, double-blind trial in comparison with heparin. Thromb Res 1993;72:475–500.
Ablin AR. Supportive care for children with cancer: Guidelines of the Childrens Cancer Study Group: managing the problem of hyperleukocytosis in acute leukemia. Am J Pediatr Hematol Oncol 1984;6:287–290.
Avvisati G, ten Cate JW, Buller HR et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukaemia. Lancet 1989;2:122–124.
Lichtman MA, Rowe JM. Hyperleukotic leukemias: rheological, clinical, and therapeutic considerations. Blood 1982;60:279–283.
Nelson SC, Bruggers CS, Kurtzberg J et al. Management of hyperleukosis with hydration, urinary alkalinization, and allopurinol: are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol 1993;15: 351–355.
Deichmann M, Helmke B, Bock M et al. Massive lethal cerebral bleeding in a patient with melanoma without intracranial metastasis. Clin Oncol 1998;10:272–273.
Packer RJ, Rorke LB, Lange BJ et al. Cerebrovascular accidents in children with cancer. Pediatrics 1985;76:194–201.
Dutcher JP, Schiffer CA, Aisner J et al. Incidence of throbocytopenia and serious hemorrhage among patients with solid tumors. Cancer 1984;53:557–562.
Kim HD, Boggs DR. A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer. Am J Med 1979;67:371–377.
Kaden BR, Rosse WF, Hauch TW. Immune thrombocytopenia in lymphoproliferative diseases. Blood 1979;53:545–551.
Eldor A. Thrombotic thrombocytopenic purpura: diagnosis, pathogenesis, and modern therapy. Baillieres Clin Haematol 1998;11:475–495.
Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost 1999;25:217–221.
Horn M, Steiner T, Gunther T et al. Reversible cerebral MRI findings in acute microangiopathic hemolytic anemia. Nervenarzt 1996;67:502–505.
Guzzini F, Conti A, Esposito F. Simultaneous ischemic and hemorrhagic lesions of the brain detected by CT scan in a patient with thrombotic thrombocytopenic purpura. Haematolojica 1998;83:280.
Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994;25:1215–1218.
Cestari DM, Weine DM, Panageas KS et al. Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025–2030.
Domenicucci M, Ramieri A, Ciapetta P et al. Nontraumatic acute spinal subdural hematoma; report of five cases and review of the literature. J Neurosurg 1999;9:65–73.
Howard SC, Gajjar A, Riberio RC et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 2000;284:2222–2224.
Omura M, Aida N, Sakido K et al. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;38:241–249.
Grill J, Couanet D, Cappelli C et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 1999;45:393–396.
Bernstein M, Lumley M, Davidson G et al. Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma. J Neurooncol 1993;17:253–260.
Fouladi M, Langston J, Mulhern R et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol 2000;18:824–831.
Casey AT, Marsh HT, Uttley D. Intracranial aneurysm formation following radiotherapy. Br J Neurosurg 1993;7:575–579.
Epstein MA, Packer RJ, Rorke LB et al. Vascular malformation with radiation vasculopathy after treatment of chiasmatic/hypothalamic glioma. Cancer 1992;70:887–893.
Poussaint TY, Siffert J, Barnes PD et al. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. Am J Neuroradiol 1995;16:693–699.
Larson JJ, Ball WS, Bove KE et al. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children. J Neurosurg 1998;88:51–56.
Cheng SW, Wu LL, Ting AC et al. Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies. Am J Surg 1999;178:323–328.
Dubec JJ, Munk PL, Tsang V et al. Carotid artery stenosis in patients who have undergone radiation therapy for head and neck malignancy. Br J Radiol 1998;71:872–875.
Murros KE, Toole J. The effect of radiation on carotid arteries. Arch Neurol 1989;46:449–455.
Andros G, Schneider PA, Harris RW et al. Management of arterial occlusive disease following radiation therapy. Cardiovasc Surg 1996;4:135–142.
Atkinson JLD, Sundt TM, Dale AJD et al. Radiation-associated atheromatous disease of the cervical carotid artery: report of seven cases and review of the literature. Neurosurgery 1989;24:171–178.
Carmody BJ, Arora S, Avena R et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg 1999;30:1045–1051.
Kashyap VS, Moore WS, Quinones-Baldrich WJ. Carotid artery repair for radiation-associated atherosclerosis is a safe and durable procedure. J Vasc Surg 1999;29:97–99
Al-Mubarak N, Roubin GS, Iyer SS et al. Carotid stenting for severe radiation-induced extracranal carotid artery occlusive disease.J Endovasc Ther 2000;7:36–40.
McCready RA, Hyde GL, Bivins BA et al: Radiation-induced arterial injuries. Surgery 1983;93:306–312.
Lang NP, Wait GM, Read RR. Cardio-cerebrovascular complications from Nd:YAG laser treatment of lung cancer. Am J Surg 1991;162:629–632.
Sessa CN, Morasch MD, Berguer R et al. Carotid resection and replacement with autogenous arterial graft during operation for neck malignancy. Ann Vasc Surg 1998;12:229–235.
Brisman MH, Sen C, Catalano P. Results of surgery for head and neck tumors that involve the carotid artery at the skull base. J Neurosurg 1997;86:787–792.
Adams GL, Madison M, Remley K et al. Preoperative permanent balloon occlusion of internal carotid artery in patients with advanced head and neck squamous cell carcinoma. Laryngoscope 1999;109:460–466.
Lorberboym M, Pandit N, Machac J et al. Brain perfusion imaging during preoperative temporary balloon occlusion of the internal carotid artery. J Nucl Med 1996;37:415–419.
Leonetti JP, Reichman OH, Silberman SJ et al. Venous infarction following translabyrinthine access to the cerebellopontine angle. Am J Otol 1994;15:723–727.
Keiper GL, Sherman JD, Tomsick TA et al. Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccitpital craniotomy and translabyrinthine craniectomy. J Neurosurg 1999;91:192–197.
Bejjani GK, Sekhar LN, Yost AM et al. Vasospasm after cranial base tumor resection: pathogenesis, diagnosis, and therapy. Surg Neurol 1999;52:571–583.
Ulmer S, Braga TA, Barker II FG et al. Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 2006;67:1668–1670.
Smith JS, Cha S, Mayo MC et al. Serial diffusion–weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 2005;103:428–438.
Catsman-Berrevoets CE, van Breemen M, van Veelen ML et al. Supratentorial arterial ischemic stroke following cerebellar tumor resection in two children. Pediatr Neurosurg 2005;41:206–211.
Kranz R, Gliemroth J, Gaebel C et al. Atypical delayed intracranial haematoma following stereotactic biopsy of a right parietal anaplastic oligodendroglioma. Clin Neurol Neurosurg 2003;105:188–192.
Mari G, Marassi A, Di Carlo V. Protein C: a new plasma protein related to post-operative hypercoagulability. Ital J Surg Sci 1984;14:9–12.
Ayala C, Blackwell KE. Protein C deficiency in microvascular head and neck reconstruction. Laryngoscope 1999;109:259–265.
Caporale A, Tirindelli MC, Aurello P et al. Evaluation of post-operative blood coagulation changes in elderly patients undergoing major surgery. Ital J Surg Sci 1989;19:51–56.
Chow KL, Gobin YP, Cloughesy T et al. Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy. Am J Neuroradiol 2000;21:471–478.
Larner JM, Phillips CD, Dion JE et al. A phase 1–2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas. Am J Clin Oncol 1995;18:1–7.
Kallmes DF, Evans AJ, Kaptain GJ et al. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology 1997;39:877–880.
Moore TB, Chow VJ, Ferry D et al. Intracardiac right-to-left shunting and the risk of stroke during bone marrow infusion. J Clin Oncol 1997;15:2510–2517.
Falanga A. Mechanisms of hypercoagulation in malignancy and during chemotherapy. Haemostasis 1998;28(suppl 3):50–60.
Lee AY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999;25:137–145.
Nordstrom B, Strang P. Microangiopathic hemolytic anemias (MAHA) in cancer: a case report and review. Anticancer Res 1993;13:1845–1849.
Schultz A, Sitzler G, Scheid C et al. A case of thrombotic thrombocytopenic purpura in an adult treated with vincristine. Ann Hematol 1999;78:39–42.
Feinberg WM, Swenson MR. Cerebrovascular complications of l–asparaginase therapy. Neurology 1988;38:127–133.
Bushman JE, Palmierir D, Whinna HC et al. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia. Leuk Res 2000;24:559–565.
Gugliotta L, Mazzucconi MG, Leone G et al. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving l–aspariginase during induction therapy: a retrospective study. Eur J Haematol 1992;49:63–66.
Matsushita K, Kuriyama Y, Sawada T et al. Cerebral infarction associated with protein C deficiency. Stroke 1992;23:108–111.
Serrano-Castro PJ, Guardado-Santervas P, Olivares-Romero J. Ischemic stroke following cisplatin and 5-fluorouracil therapy: a transcranial Doppler study. Eur Neurol 2000;44:63–64.
Gamble GE, Tyrrell P. Acute stroke following cisplatin therapy. Clin Oncol 1998;10:274–275.
Taher A, Shamsseddine A, Saghir N et al. Acquired protein C deficiency following cisplatinum–navelbine administration for locally advanced breast cancer: case report. Eur J Gynaecol Oncol 1999;20:323–324.
Chan AT, Yeo W, Leung WT et al. Thromboembolic events with paclitaxel. Clin Oncol 1996;8:133.
Fisher B, Constantino JP, Wickerham et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–1388.
Barbui T, Finazzi G, Grassi A et al. Thrombosis in cancer patients treated with hematopoietic growth factor: a meta-analysis. Thromb Haemost 1996;75:368–371.
Kabbinavar FF, Schulz J, McCleod M et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005;23:3697–3705.
Vrendenburgh JJ, Desjardins A, Herndon II J et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 2007;13:1253–1259.
Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf 2000;22:263–302.
Mathur SC, Friedman HD, Kende AI et al. Cryptic Mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy. Ann Hematol 1999;78:241–245.
Mammen EF. The haematological manifestations of sepsis. J Antimicrob Chemother 1998;41(suppl A):17–24.
Schiff D, DeAngelis LM. Therapy of venous thromboembolism in patients with brain metastasis. Cancer 1994;73:493–498.
Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998;22:351–357.
Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14:495–504.
Colosimo M, McCarthy N, Jayasinghe R et al. Diagnosis and management of subdural haematoma complicating bone marrow transplantation. Bone Marrow Transplant 2000;25:549–552.
Graus F, Saiz A, Sierra J et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996;46:1004–1009.
Coplin WM, Cochran MS, Levine SR et al. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001;124:1043–1051.
Bleggi-Torres LF, Werner B, Gasparetto EL et al. Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients. Bone Marrow Transplant 2002;29:29–32.
Patchell RA, White CL, Clark AW et al. Nonbacterial thrombotic endocarditis in bone marrow transplant patients. Cancer 1985;55:631–635.
Ma M, Barnes G, Pulliam J et al. CNS angiitis in graft vs. host disease. Neurology 2005;59:1994–1997.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Rogers, L.R., Leary, M.C., Saver, J.L. (2008). Cerebrovascular Complications of Cancer. In: Schiff, D., Kesari, S., Wen, P.Y. (eds) Cancer Neurology In Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-412-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-59745-412-4_14
Publisher Name: Humana Press
Print ISBN: 978-1-58829-983-3
Online ISBN: 978-1-59745-412-4
eBook Packages: MedicineMedicine (R0)